Following chemotherapy for breast cancer, ONECUT2 induces tumor stemness and triggers the expression of stem cell-related genes, including SOX9, SOX2, and NOTCH1, thereby contributing to chemoresistance [25]. Here, SOX9 is linked to breast cancer.